Therapeutic Drug Monitoring Newer Drugs And Biomarkers 2Ed at Meripustak

Therapeutic Drug Monitoring Newer Drugs And Biomarkers 2Ed

Books from same Author: Dasgupta

Books from same Publisher: Elsevier

Related Category: Author List / Publisher List


  • Retail Price: ₹ 18040/- [ 0.00% off ]

    Seller Price: ₹ 18040

Sold By: T K Pandey      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 0.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 0.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Dasgupta
    PublisherElsevier
    Edition2nd Edition
    ISBN9780443186493
    Pages578
    BindingHardcover
    LanguageEnglish
    Publish YearMay 2024

    Description

    Elsevier Therapeutic Drug Monitoring Newer Drugs And Biomarkers 2Ed by Dasgupta

    Therapeutic Drug Monitoring: Newer Drugs and Biomarkers, Second Edition is an updated reference on TDM analytical techniques in diverse clinical settings. This new edition reviews exciting new developments in the area, including seven new chapters covering immunoassay design and applications, combined chromatographic techniques in therapeutic monitoring, drug monitoring in alternative specimens, pharmacogenomics of anticancer drugs, pharmacogenomics testing for patient management, selected antifungal agents, pharmacodynamic monitoring, and therapeutic drug monitoring of selected anticoagulants. All remaining chapters in the first edition were thoroughly revised and updated. This book is the ideal reference for clinical pathologists, pharmacologists, and toxicologists involved with TDM. Scientists working in diagnostic companies, developing reagents for monitoring therapeutic drugs will also find relevant information in this book.Includes new chapters covering antifungal, anticoagulant, and anticancer drugs monitoringDiscusses limitations of current immunoassays, new and sophisticated chromatographic techniques, the clinical effectiveness of newer antiretroviral agents, anticonvulsants and antidepressantsProvides full coverage of pharmacogenomics and personalized medicine, principles of pharmacokinetics and pharmacodynamics, and the application of biomarkers in TDM